André Ribeiro

Take the #EXPLOREPsA survey 🧭 — led by #YoungGRAPPA to learn how PsA disease activity is assessed globally. 🕐 5–10 min 🌍 Worldwide participation welcome 🔗app.onlinesurveys.jisc.ac.uk/s/oxford/explo… @GrappaO @reumacia @rheum_cat @Lupusreference

Join our efforts 🙌🏻

I'm glad for this comment. Because this is exactly the mistake that is being made all over the world. You see a Doppler signal at the enthesis and always postulate spondyloarthritis etc. THIS IS COMPLETELY WRONG. there are several other diseases that can lead to a positive…

Working with PsA and want to improve your imaging skills? Join us for the GRAPPA Workshop at #APLAR25 on 4 September for insights into the AXIS study, MRI advances and real case discussions. Register now to attend for $100: tinyurl.com/APLARWorkshop

🌍 Are you a young rheumatologist from Sub-Saharan Africa? 🎓 Don’t miss this chance to register for FREE EULAR online courses by september 15th! 📚 Boost your knowledge, and advance your career in rheumatology. 👉 Apply now: pulse.ly/br4o9cg6cn #EULAR

#Exercise-induced #cortisol secretion suppress cortisol response to #stress ▶️Even single bout of exercise at increased intensities reduces acute HPA-axis stress response compared to milder intensity bouts 👉🏽sciencedirect.com/science/articl… via @PNECJournal

New! ✨ The 2024 EULAR recommendations on the use of antirheumatic drugs during reproduction, pregnancy 🤰, and lactation 🍼 are out! Highlights: safe options for women & men, updated guidance for NSAIDs, GCs, bDMARDs, and more

Bogotá rewind—faces of progress in psoriatic disease. 📸✨ 13‑second flashback to #GRAPPA2025: spirited rheum‑derm collaboration & Colombian warmth. See someone you know? Tag them and keep the momentum! #PsoriaticDisease #RheumDermCollab

It’s an honor to promote free education in Musculoskeletal Ultrasound (#MSUS) and Rheumatology. We are happy to share the MSUS Database: over 1,000 images and videos of sonoanatomy and pathology, accessible with a single click from anywhere in the world 🌍 🌎 , even where…

@CrusSurc advanced injection and procedures course 💉💉💉 Ottawa 🇨🇦 in November 2025 details below 👇👇👇 - hope to see you soon!

Biologic survival study of British Assoc. of Dermatologists Biologics Register (11/07-6/23) looked at 19,034 Rx courses (median F/U 2.3 yrs), of TNFi, IL-12/23i, IL-17i, & IL-23i. IL-23i (GUS & RIS) had best survival (~1.93yrs) for efficacy & safety (broadalumab the least)…

🚀Join us on the EULAR - EMEUNET webinar: "From Gut to Joint - Essential Insights for Rheumatologists and Gastroenterologists". 🖥️Tuesday, 9 September 2025, 19:00 - 20:00 CEST Register here: pulse.ly/mhnovuhkaz #Rheumatology #IBD

🔥 Chronic inflammation increases CV risk in #axSpA ✅ 245 pts — “High-CRP” = >5 mg/L in >50 % of tests (40%) ➡️ ↑ Plaques, IR & dyslipidaemia; microvascular flow ↓ ⚠️ IL-6 & CDCP-1 → CIMT ↑ & endothelial dysfunction 🛡️ PON-3 ↓ restoring endothelial health in vitro 💉…

📢 New article in @RheumJnl 🔬 Baseline NFC abnormalities predict ILD progression and lung function decline in SSc over 2 years follow-up 📉 Late NVC patterns at baseline linked to worsening KL-6, mRSS, and %DLCO during follow-up 👉 doi.org/10.1093/rheuma…

Happy (or more like relieved 🫠❣️) to finally share that my work is out! It definitely took a while, but I’ve learned so much along the way. Even more grateful that I get to keep going on this research journey for a few more years🙏!! #Sjogren #Tfh 🔗nature.com/articles/s4159…

Our paper is out! We show that GM-CSF drives early bone damage in RA—even before arthritis begins—and that JAK inhibitors can suppress this progression. A long journey, but worth it! doi.org/10.1186/s13075…

Day 3 of #APLAR25 features Plenary Session 3 on cutting-edge translational research in autoimmune disease. Hear from Dr. Pascual, Prof. Schett & Dr. Kim on lupus, B-cell therapy & immune pathways. View the full program: tinyurl.com/APLAR25-Program

📣Happening tomorrow✨ July 23rd is #WorldSjogrensDay 😊 To raise awareness, an exciting webinar hosted by @APLAR_org will be held tomorrow📺👇 Register🔗 us06web.zoom.us/webinar/regist… #Sjogren #AYR #APLAR @JCRheum

📣How is #PsA disease activity assessed in your country 🤔?? @APLAR_org #AYR Reminded me of the #JSTAR session during #JCR2025 😊 皮膚のスコアどうしてますか？とかｲﾛｲﾛ23時近くにzoomで話し合ったの、とても良い思い出です😂♡